Broadwood Capital Inc 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
Broadwood Capital Inc disclosed 7 US equity positions worth $1.7bn in its Q3 2025 13F filing. The largest position was MNST at 33.6% of the reported book, followed by AXON and STAA. Against the Q2 2025 filing, it opened 0 new positions, added to 0 and reduced 1 among the top 7 holdings.
What did Broadwood Capital Inc own in Q3 2025? Top 7 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | MNST MONSTER BEVERAGE CORP NEW | Consumer Defensive | 33.6% | $555.3m | 8,250,428 | -0% | held |
| 2 | AXON AXON ENTERPRISE INC | Industrials | 30.1% | $497.7m | 693,504 | -0% | held |
| 3 | STAA STAAR SURGICAL CO | Healthcare | 22.0% | $363.3m | 13,519,491 | 0% | held |
| 4 | IWM ISHARES TR | 7.0% | $114.9m | 474,920 | 0% | held | |
| 5 | LCTX LINEAGE CELL THERAPEUTICS IN | 5.1% | $83.8m | 49,560,992 | 0% | held | |
| 6 | IMDX INSIGHT MOLECULAR DIA INC | 2.3% | $37.9m | 11,410,100 | 0% | held | |
| 7 | SERINA THERAPEUTICS INC | 0.0% | $445.9k | 83,195 | -2% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.